We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$134M
(+15%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
9.82%
Top 10 Holdings %
Top 10 Hldgs %
32.7%
Holding
2,551
New
200
Increased
686
Reduced
655
Closed
183
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
1.4
years
Top 20 Avg Time Held Equity + Options
1.4
years
Avg Time Held Equity only
1.8
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$59.5M |
| 2 |
Microsoft
MSFT
|
+$35.4M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$14.4M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$11M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$9.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$34.9M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$14.6M |
| 3 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$6.59M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$3.46M |
| 5 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.06% |
| 2 | Technology | 12.78% |
| 3 | Financials | 6.64% |
| 4 | Communication Services | 4.79% |
| 5 | Healthcare | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IPHS
1676
DELISTED
Innophos Holdings, Inc.
IPHS
| $8K | ﹤0.01% |
266
| – | – |
2017 Q1
9 quarters
|
|
1677
DELISTED
Healthcare Realty Trust Incorporated
HR
| $8K | ﹤0.01% |
262
-231
| -47% | -$7.32K |
2017 Q1
9 quarters
|
|
1678
Allogene Therapeutics
ALLO
$449M
| $7K | ﹤0.01% |
252
| – | – |
2019 Q1
1 quarter
|
|
1679
A.O. Smith
AOS
$8.1B
| $7K | ﹤0.01% |
141
-151
| -52% | -$7.4K |
2016 Q4
10 quarters
|
|
1680
Aptevo Therapeutics
APVO
$3.04M
| – | – |
0
| – | – |
2018 Q1
5 quarters
|
|
1681
Coeur Mining
CDE
$16B
| $7K | ﹤0.01% |
1,499
+1,498
| +149,800% | +$5.27K |
2019 Q1
1 quarter
|
|
1682
Community Healthcare Trust
CHCT
$382M
| $7K | ﹤0.01% |
183
| – | – |
2017 Q1
9 quarters
|
|
1683
CEMIG Preferred Shares
CIG
$6.55B
| $7K | ﹤0.01% |
3,718
+328
| +10% | +$603 |
2018 Q3
3 quarters
|
|
1684
Carter's
CRI
$1.17B
| $7K | ﹤0.01% |
75
| – | – |
2016 Q4
10 quarters
|
|
1685
China Yuchai International
CYD
$989M
| $7K | ﹤0.01% |
462
+246
| +114% | +$3.8K |
2019 Q1
1 quarter
|
|
1686
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$888M
| $7K | ﹤0.01% |
300
| – | – |
2017 Q4
6 quarters
|
|
1687
iShares Emerging Markets Dividend ETF
DVYE
$1.2B
| $7K | ﹤0.01% |
165
+1
| +0.6% | +$40 |
2016 Q4
10 quarters
|
|
1688
EnerSys
ENS
$6.19B
| $7K | ﹤0.01% |
100
| – | – |
2016 Q4
10 quarters
|
|
1689
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $7K | ﹤0.01% |
150
| – | – |
2016 Q4
10 quarters
|
|
1690
Eagle Materials
EXP
$5.24B
| $7K | ﹤0.01% |
74
-136
| -65% | -$12K |
2017 Q1
9 quarters
|
|
1691
iShare MSCI Eurozone ETF
EZU
$9.26B
| $7K | ﹤0.01% |
173
-172
| -50% | -$6.78K |
2017 Q1
9 quarters
|
|
1692
First Commonwealth Financial
FCF
$2.05B
| $7K | ﹤0.01% |
485
| – | – |
2016 Q4
10 quarters
|
|
1693
Green Dot
GDOT
$699M
| $7K | ﹤0.01% |
+141
| New | +$7.68K |
2019 Q2
0 quarters
|
|
1694
Genesis Energy
GEL
$1.72B
| $7K | ﹤0.01% |
340
| – | – |
2018 Q2
4 quarters
|
|
1695
Gerdau
GGB
$9.95B
| $7K | ﹤0.01% |
2,167
| – | – |
2017 Q2
8 quarters
|
|
1696
iQIYI
IQ
$925M
| $7K | ﹤0.01% |
+321
| New | +$6.63K |
2019 Q2
0 quarters
|
|
1697
DELISTED
iRobot
IRBT
| $7K | ﹤0.01% |
73
| – | – |
2019 Q1
1 quarter
|
|
1698
Coca-Cola Femsa
KOF
$25B
| $7K | ﹤0.01% |
113
| – | – |
2018 Q3
3 quarters
|
|
1699
LCI Industries
LCII
$2.08B
| $7K | ﹤0.01% |
73
| – | – |
2019 Q1
1 quarter
|
|
1700
Manulife Financial
MFC
$73B
| $7K | ﹤0.01% |
407
| – | – |
2016 Q4
10 quarters
|
|
Similar funds
Parallel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Parallel Advisors held 2,551 positions worth $1.03B, up 15% from $891M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Parallel Advisors deployed $101M of net new capital in Q2 2019, opening 200 new positions and adding to 686 existing holdings. Its largest new stake was Onto Innovation: 157,557 shares worth $5.47M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 56% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $34.9M trimmed.
- Parallel Advisors's largest Q2 2019 buy was Onto Innovation: 157,557 shares worth $5.47M.
- Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q2 2019, an estimated $59.5M increase.
- Parallel Advisors's biggest Q2 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $34.9M.
- Parallel Advisors fully exited Vanguard Short-Term Treasury ETF in Q2 2019, selling an estimated $553K.
- Parallel Advisors's ten largest holdings make up 33% of its $1.03B portfolio in Q2 2019.
- Parallel Advisors opened 200 new positions and closed 183 in Q2 2019.
- Parallel Advisors's portfolio value rose 15% quarter-over-quarter to $1.03B.
Based on Parallel Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.